Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/4/860/366836/mdp508.pdf
Reference32 articles.
1. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphoma. A prospective study of 361 immunophenotyped patients treated with LNH-84 regimen;Coiffier;Ann Oncol,1990
2. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype;Lippman;Blood,1988
3. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin’s lymphoma;Armitage;J Clin Oncol,1989
4. T-cell non-Hodgkin’s lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors;Reiser;Leuk Lymphoma,2002
5. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen: a multi-center study. Kiel Lymphoma Study Group;Siegert;Ann Intern Med,1992
Cited by 159 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01
2. Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas;Leukemia & Lymphoma;2023-12-13
3. Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL);Clinical Epigenetics;2023-08-02
4. Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma;Bone Marrow Transplantation;2022-08-22
5. Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study;Leukemia & Lymphoma;2022-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3